TrialJAMA network open2024

Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Amir Goldkorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.